| Business Summary | | Pacific
Biometrics,
Inc.
(PBI)
is
a
development
stage
company
that
provides
specialty
reference
laboratory
services
to
the
pharmaceutical
and
diagnostics
industries.
PBI
had
previously
been
engaged
in
the
development
and
commercialization
of
non-invasive
technologies
for
use
in
diagnostics
to
improve
the
detection
and
management
of
chronic
diseases.
The
Company
terminated
its
commercialization
efforts
due
to
its
inability
to
obtain
FDA
(Food
and
Drug
Administration)
approval
for
its
OsteoPatch
product
and
lack
of
necessary
funding.
PBI
has
developed
two
patented
platform
technologies
that
permit
the
use
of
sweat
and
saliva
as
diagnostic
fluids.
The
Company's
intellectual
property
position
in
both
sweat
and
saliva
collection
technology
is
based
on
16
issued
U.S.
patents
and
one
pending
U.S.
patent
with
respect
to
its
SalivaSac
technology.
The
Company
has
ceased
all
product
development
activities
due
to
a
lack
of
funds. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Pacific
Biometrics,
Inc.
is
a
development
stage
enterprise
engaged
in
the
research
and
commercialization
of
non-invasive
diagnostic
products
for
the
detection
and
management
of
chronic
diseases.
For
the
nine
months
ended
3/31/01,
revenues
rose
29%
to
$1.4
million.
Net
loss
applicable
to
Common
fell
71%
to
$219
thousand.
Results
reflect
a
higher
level
of
contract
research
work
performed,
cost
reduction
efforts
and
lower
interest
expense. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| Paul Kanan, 54 Pres,
CEO | $200K | Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|